L-type Ca 2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory

Molecular Psychiatry

Volumn 21, Issue 3, 2016, Pages 394-402

  Degoulet, M ^a   Stelly, C E ^a   Ahn, K C ^a,b   Morikawa, H ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; ISRADIPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINO ACID RECEPTOR AFFECTING AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTEXTUAL MEMORY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG DEPENDENCE; ELECTROPHYSIOLOGICAL PROCEDURES; EXCITATORY POSTSYNAPTIC POTENTIAL; GLUTAMATERGIC TRANSMISSION; LONG TERM POTENTIATION; MALE; MEMORY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECTS; DRUG INTERACTION; ELECTROSTIMULATION; IN VITRO STUDY; INSTRUMENTAL CONDITIONING; PATCH CLAMP TECHNIQUE; REINFORCEMENT; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; COCAINE; CONDITIONING, OPERANT; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGENTS; EXTINCTION, PSYCHOLOGICAL; IN VITRO TECHNIQUES; ISRADIPINE; LONG-TERM POTENTIATION; MALE; MEMORY; NEUROTRANSMITTER AGENTS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 84958921657     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.84     Document Type: Article

References (67)

1. Wise RA, Kiyatkin EA. Differentiating the rapid actions of cocaine. Nat Rev Neurosci 2011; 12: 479-484.
2. Robinson TE, Yager LM, Cogan ES, Saunders BT. On the motivational properties of reward cues: individual differences. Neuropharmacology 2014; 76(Pt B): 450-459.
3. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays 2010; 32: 748-755.
4. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006; 29: 565-598.
5. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci 2007; 8: 844-858.
6. Luthi A, Luscher C. Pathological circuit function underlying addiction and anxiety disorders. Nat Neurosci 2014; 17: 1635-1643.
7. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 1998; 80: 1-27.
8. Overton PG, Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev 1997; 25: 312-334.
9. Zweifel LS, Parker JG, Lobb CJ, Rainwater A, Wall VZ, Fadok JP., et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci USA 2009; 106: 7281-7288.
10. Morikawa H, Khodakhah K, Williams JT. Two intracellular pathways mediate metabotropic glutamate receptor-induced Ca2+ mobilization in dopamine neurons. J Neurosci 2003; 23: 149-157.
11. Wang LP, Li F, Wang D, Xie K, Wang D, Shen X., et al. NMDA receptors in dopaminergic neurons are crucial for habit learning. Neuron 2011; 72: 1055-1066.
12. Deister CA, Teagarden MA, Wilson CJ, Paladini CA. An intrinsic neuronal oscillator underlies dopaminergic neuron bursting. J Neurosci 2009; 29: 15888-15897.
13. Blythe SN, Atherton JF, Bevan MD. Synaptic activation of dendritic AMPA and NMDA receptors generates transient high-frequency firing in substantia nigra dopamine neurons in vitro. J Neurophysiol 2007; 97: 2837-2850.
14. Harnett MT, Bernier BE, Ahn KC, Morikawa H. Burst-timing-dependent plasticity of NMDA receptor-mediated transmission in midbrain dopamine neurons. Neuron 2009; 62: 826-838.
15. Brown J, Bullock D, Grossberg S. How the basal ganglia use parallel excitatory and inhibitory learning pathways to selectively respond to unexpected rewarding cues. J Neurosci 1999; 19: 10502-10511.
16. Cui G, Bernier BE, Harnett MT, Morikawa H. Differential regulation of action potential- and metabotropic glutamate receptor-induced Ca2+ signals by inositol 1, 4, 5-trisphosphate in dopaminergic neurons. J Neurosci 2007; 27: 4776-4785.
17. Zuccotti A, Clementi S, Reinbothe T, Torrente A, Vandael DH, Pirone A. Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting. Trends Pharmacol Sci 2011; 32: 366-375.
18. Lipscombe D, Helton TD, Xu W. L-type calcium channels: the low down. J Neurophysiol 2004; 92: 2633-2641.
19. Rajadhyaksha A, Husson I, Satpute SS, Kuppenbender KD, Ren JQ, Guerriero RM., et al. L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. J Neurosci 2004; 24: 7464-7476.
20. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T., et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 2007; 447: 1081-1086.
21. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT., et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 2010; 468: 696-700.
22. Branch SY, Sharma R, Beckstead MJ. Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons. J Neurosci 2014; 34: 9310-9318.
23. Pani L, Kuzmin A, Martellotta MC, Gessa GL, Fratta W. The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res Bull 1991; 26: 445-447.
24. Pucilowski O, Plaznik A, Overstreet DH. Isradipine suppresses amphetamineinduced conditioned place preference and locomotor stimulation in the rat. Neuropsychopharmacology 1995; 12: 239-244.
25. Biala G, Langwinski R. Effects of calcium channel antagonists on the reinforcing properties of morphine, ethanol and cocaine as measured by place conditioning. J Physiol Pharmacol 1996; 47: 497-502.
26. Pucilowski O, Garges PL, Rezvani AH, Hutheson S, Janowsky DS. Verapamil suppresses d-Amphetamine-induced place preference conditioning. Eur J Pharmacol 1993; 240: 89-92.
27. Wang LP, Li F, Shen X, Tsien JZ. Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference. PLoS One 2010; 5: e8616.
28. Zweifel LS, Argilli E, Bonci A, Palmiter RD. Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron 2008; 59: 486-496.
29. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007; 12: 227-462.
30. Engblom D, Bilbao A, Sanchis-Segura C, Dahan L, Perreau-Lenz S, Balland B., et al. Glutamate receptors on dopamine neurons control the persistence of cocaine seeking. Neuron 2008; 59: 497-508.
31. Whitaker LR, Degoulet M, Morikawa H. Social deprivation enhances VTA synaptic plasticity and drug-induced contextual learning. Neuron 2013; 77: 335-345.
32. Ahn KC, Bernier BE, Harnett MT, Morikawa H. IP3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area. J Neurosci 2010; 30: 6689-6699.
33. Bernier BE, Whitaker LR, Morikawa H. Previous ethanol experience enhances synaptic plasticity of NMDA receptors in the ventral tegmental area. J Neurosci 2011; 31: 5205-5212.
34. Khaliq ZM, Bean BP. Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci 2010; 30: 7401-7413.
35. Koulchitsky S, De Backer B, Quertemont E, Charlier C, Seutin V. Differential effects of cocaine on dopamine neuron firing in awake and anesthetized rats. Neuropsychopharmacology 2012; 37: 1559-1571.
36. Ungless MA, Whistler JL, Malenka RC, Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001; 411: 583-587.
37. Borgland SL, Malenka RC, Bonci A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 2004; 24: 7482-7490.
38. Yuan T, Mameli M, O' Connor EC, Dey PN, Verpelli C, Sala C., et al. Expression of cocaine-evoked synaptic plasticity by GluN3A-containing NMDA receptors. Neuron 2013; 80: 1025-1038.
39. Mameli M, Bellone C, Brown MT, Luscher C. Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area. Nat Neurosci 2011; 14: 414-416.
40. Chen BT, Bowers MS, Martin M, Hopf FW, Guillory AM, Carelli RM., et al. Cocaine but not natural reward self-Administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron 2008; 59: 288-297.
41. Bellone C, Luscher C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci 2006; 9: 636-641.
42. Kang S, Cooper G, Dunne SF, Dusel B, Luan CH, Surmeier DJ., et al. CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Nat Commun 2012; 3: 1146.
43. Torregrossa MM, Taylor JR. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction. Psychopharmacology (Berl) 2013; 226: 659-672.
44. Milton AL, Everitt BJ. The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments. Neurosci Biobehav Rev 2012; 36: 1119-1139.
45. Xue YX, Luo YX, Wu P, Shi HS, Xue LF, Chen C., et al. A memory retrieval-extinction procedure to prevent drug craving and relapse. Science 2012; 336: 241-245.
46. Lee AM, Kanter BR, Wang D, Lim JP, Zou ME, Qiu C., et al. Prkcz null mice show normal learning and memory. Nature 2013; 493: 416-419.
47. Li YQ, Xue YX, He YY, Li FQ, Xue LF, Xu CM., et al. Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory. J Neurosci 2011; 31: 5436-5446.
48. Group PS. Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADYPD). Mov Disord 2013; 28: 1823-1831.
49. Ilijic E, Guzman JN, Surmeier DJ. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease. Neurobiol Dis 2011; 43: 364-371.
50. Moosmang S, Haider N, Klugbauer N, Adelsberger H, Langwieser N, Muller J., et al. Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci 2005; 25: 9883-9892.
51. Seoane A, Massey PV, Keen H, Bashir ZI, Brown MW. L-type voltage-dependent calcium channel antagonists impair perirhinal long-term recognition memory and plasticity processes. J Neurosci 2009; 29: 9534-9544.
52. Adermark L, Lovinger DM. Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. J Neurosci 2007; 27: 6781-6787.
53. Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J., et al. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 2006; 50: 443-452.
54. Hunt DL, Castillo PE. Synaptic plasticity of NMDA receptors: mechanisms and functional implications. Curr Opin Neurobiol 2012; 22: 496-508.
55. Rebola N, Srikumar BN, Mulle C. Activity-dependent synaptic plasticity of NMDA receptors. J Physiol 2010; 588: 93-99.
56. Bauer EP, Schafe GE, LeDoux JE. NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci 2002; 22: 5239-5249.
57. Langwieser N, Christel CJ, Kleppisch T, Hofmann F, Wotjak CT, Moosmang S. Homeostatic switch in hebbian plasticity and fear learning after sustained loss of Cav1.2 calcium channels. J Neurosci 2010; 30: 8367-8375.
58. Davis SE, Bauer EP. L-type voltage-gated calcium channels in the basolateral amygdala are necessary for fear extinction. J Neurosci 2012; 32: 13582-13586.
59. Pare D, Duvarci S. Amygdala microcircuits mediating fear expression and extinction. Curr Opin Neurobiol 2012; 22: 717-723.
60. Nabavi S, Fox R, Proulx CD, Lin JY, Tsien RY, Malinow R. Engineering a memory with LTD and LTP. Nature 2014; 511: 348-352.
61. Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010; 11: 682-696.
62. Turrigiano G. Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function. Cold Spring Harb Perspect Biol 2012; 4: a005736.
63. Pan WX, Schmidt R, Wickens JR, Hyland BI. Tripartite mechanism of extinction suggested by dopamine neuron activity and temporal difference model. J Neurosci 2008; 28: 9619-9631.
64. Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE., et al. CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci 2008; 11: 344-353.
65. Johnson BA, Javors MA, Lam YW, Wells LT, Tiouririne M, Roache JD., et al. Kinetic and cardiovascular comparison of immediate-release isradipine and sustainedrelease isradipine among non-treatment-seeking, cocaine-dependent individuals. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 15-20.
66. Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT., et al. Effects of repeated-dose isradipine on the abuse liability of cocaine. Exp Clin Psychopharmacol 2005; 13: 319-326.
67. Johnson BA, Roache JD, Ait-Daoud N, Wallace CL, Wells LT, Wang Y., et al. Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. Int J Neuropsychopharmacol 2005; 8: 549-556.